Stockreport

Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF The stock has quietly put up some strong numbers, with shares up 1.5% over the last week, 18.3% over the last month, 45.0% year to date, and 201.0% over three years. [Read more]